Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Zika virus

Cases of Zika virus infection detected in Scotland

The aedes mosquito, carrier of the Zika virus


The Aedes mosquito that spreads the Zika virus is not found in the UK

Five people in Scotland have been diagnosed with Zika virus infection, the Scottish government has confirmed.

Since the outbreak began in Brazil in 2015, 60 people have been diagnosed with Zika virus infection in the UK. All of them had returned from overseas. Only these five cases have been found in Scotland.

A spokesperson for the Scottish government said: “We can assure the public that Zika does not pose a public health risk in Scotland, and of the cases identified in the UK a very small number have been found in Scotland.

“The mosquito that spreads the virus is not found in the UK, and in any case would not be able to establish in Scotland because of our climate.”

Health Protection Scotland advises healthcare professionals to be alert to the possibility of Zika infection in people with fever who have recently returned from Zika-affected areas or who have a sexual partner who has returned from one of these areas in the previous eight weeks. They say this is particularly important in women of childbearing age who are, or could be, pregnant.

Health Protection Scotland issues updated travel health guidance to healthcare professionals via the Travax website. The Scottish government spokesperson adds: “We have already informed the at-risk groups about the risks and how to protect themselves through Health Protection Scotland’s travel advice. We continue to closely monitor developments in our understanding of the Zika virus as treatments and testing regimes develop.”

Three vaccines in development have proven to be effective against Zika in primate models, with data published in Nature[1] and Science[2].

There have been more than 500,000 suspected or confirmed Zika cases in affected regions during this outbreak, predominantly in south and central America and the Caribbean. The virus is usually thought to be mild and does not result in symptoms in the majority of people, but it has been linked to the development of microcephaly in babies born to women infected with the virus. Most cases have been spread via Aedes mosquitoes and a small but growing number have been attributed to sexual transmission.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2016.20201542

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

RPS publications

Pharmaceutical Press is the publishing division of the Royal Pharmaceutical Society, and is a leading provider of authoritative pharmaceutical information used throughout the world.

  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • The aedes mosquito, carrier of the Zika virus

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.